Photodynamic activity study of palladium(II) meso-tetrakis(4-sulfonatophenyl)porphyrin sensitizer on cancer cell line A549

被引:0
作者
Kolar, Petr [1 ,2 ]
Kolarova, Hana [1 ]
Tomankova, Katerina [1 ]
Mosinger, Jiri [3 ]
机构
[1] Palacky Univ, Dept Med Biophys, Fac Med, Hnevotinska 3, Olomouc 77515, Czech Republic
[2] Univ Hosp Olomouc, Dept Orthoped, Olomouc, Czech Republic
[3] Charles Univ Prague, Fac Sci, Dept Inorgan Chem, Prague, Czech Republic
来源
METAL IONS IN BIOLOGY AND MEDICINE, VOL 10 | 2008年 / 10卷
关键词
photodynamic therapy; PdTPPS4; sensitizer; light; reactive oxygen species; A549 cancer cells;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Photodynamic therapy uses the interaction of sensitizers and light to destroy cancerous cells and tumors. The photochemical interactions of sensitizer, light, and molecular oxygen produce singlet oxygen and other forms of active oxygen, such as peroxide, hydroxyl radical and superoxide ion. The cellular effects include membrane damage, mitochondrial damage and DNA damage. We report the production of reactive oxygen species and the phototoxicity of photodynamic sensitizer palladium(II) meso-tetrakis(4-sulfonatophenyl)porphyrin (PdTPPS4) on human lung cancer cell lines A549. The light emitting diodes (LEDs) were used as a source for evocation of the photodynamic effect. We investigate the concentration dose dependency of sensitizer in combination with LEDs irradiation on photodamage of cancer cells by in vitro methods. Viability of cells was determined by MTT assay. The quantitative changes of cell viability in relation to sensitizer concentrations and irradiation doses were proved by fluorometric measurement. A549 cells are sensitive to photodynamic damage and our results indicate decrease of viability and time-course of ROS production within A549 cells during photodynamic therapy in vitro.
引用
收藏
页码:500 / +
页数:3
相关论文
共 18 条
  • [1] Photosensitizers in clinical PDT
    Allison, Ron R.
    Downie, Gordon H.
    Cuenca, Rosa
    Hu, Xin-Hua
    Childs, Carter J. H.
    Sibata, Claudio H.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2004, 1 (01) : 27 - 42
  • [2] Dahle J, 1999, PHOTOCHEM PHOTOBIOL, V70, P363, DOI 10.1562/0031-8655(1999)070<0363:TMOCDI>2.3.CO
  • [3] 2
  • [4] Photodynamic therapy
    Dougherty, TJ
    Gomer, CJ
    Henderson, BW
    Jori, G
    Kessel, D
    Korbelik, M
    Moan, J
    Peng, Q
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12): : 889 - 905
  • [5] The role of subcellular localization in initiation of apoptosis by photodynamic therapy
    Kessel, D
    Luo, Y
    Deng, YQ
    Chang, CK
    [J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1997, 65 (03) : 422 - 426
  • [6] KESSEL D, 2004, PHOTODIAGN PHOTODYN, P3
  • [7] Kolárová H, 1999, LASER SURG MED, V24, P231, DOI 10.1002/(SICI)1096-9101(1999)24:3<231::AID-LSM8>3.0.CO
  • [8] 2-#
  • [9] Photodynamic therapy with zinc-tetra(p-sulfophenyl)porphyrin bound to cyclodextrin induces single strand breaks of cellular DNA in G361 melanoma cells
    Kolarova, H
    Maceeek, J
    Nevrelova, P
    Huf, M
    Tomecka, M
    Bajgar, R
    Mosinger, J
    Strnad, M
    [J]. TOXICOLOGY IN VITRO, 2005, 19 (07) : 971 - 974
  • [10] In vitro toxicity testing of supramolecular sensitizers for photodynamic therapy
    Kolárová, H
    Mosinger, J
    Lenobel, R
    Kejlová, K
    Jírová, D
    Strnad, M
    [J]. TOXICOLOGY IN VITRO, 2003, 17 (5-6) : 775 - 778